Cover Image
市場調查報告書

電力藥學/生物電療的全球市場預測 2021年:心臟心律調節器、人工電子耳、脊髓刺激設備 (SCS)

Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 361360
出版日期 內容資訊 英文 219 Pages
訂單完成後即時交付
價格
Back to Top
電力藥學/生物電療的全球市場預測 2021年:心臟心律調節器、人工電子耳、脊髓刺激設備 (SCS) Electroceuticals/Bioelectric Medicine Market by Product (Pacemakers, Cochlear Implants, Spinal Cord Stimulators), Type of Device (Implantable, Non-Invasive), Application (Arrhythmia, Depression, Migraine), End User (Hospitals) - Global Forecast to 2021
出版日期: 2016年06月06日 內容資訊: 英文 219 Pages
簡介

全球電力藥學/生物電療市場,預計從2016年到2021年以7.9%的年複合成長率發展,從2016年的172億美元,到2021年達到252億美元。

本報告以全球電力藥學/生物電療市場為焦點,提供產品、設備的種類、應用、終端用戶,及地區等各分類的預測,市場現狀,發展的影響要素,競爭環境,主要企業等相關的調查、分析資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 應特別記載考察點

  • 全球電力藥學市場
  • 全球電力藥學市場:各產品
  • 全球電力藥學市場:各地區、腦深部刺激應用領域
  • 全球電力藥學市場:各地區
  • 全球電力藥學市場:各終端用戶

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 機會
    • 課題

第6章 全球電力藥學市場:各產品

  • 簡介
  • 植入式心臟整流去顫器 (ICD)
  • 心臟心律調節器
  • 脊髓刺激設備 (SCS)
  • 人工電子耳
  • 深層腦部刺激器 (DBS)
  • 經皮末梢神經電刺激 (TENS)
  • 迷走神經刺激設備 (VNS)
  • 薦骨神經刺激器 (SNS)
  • 視網膜移植
  • 其他電刺激設備

第7章 全球電力藥學市場:設備的各類型

  • 簡介
  • 樹叢型電力藥學設備
  • 非侵襲電力藥學設備

第8章 全球電力藥學市場:各應用領域

  • 簡介
  • 心臟心律調節器、植入式心臟整流去顫器 (ICD) 市場:各應用領域
    • 心律不整
  • 脊髓刺激設備 (SCS) 市場:各應用領域
    • 慢性疼痛
    • 脊椎手術後疼痛症候群 (FBSS)
    • 局部貧血
  • 人工電子耳市場:各應用領域
    • 感覺神經性聽力損失
  • 深層腦部刺激器 (DBS) 市場:各應用領域
    • 帕金森氏症
    • 麻痺
    • 憂鬱症
    • 其他
  • 經皮末梢神經電刺激 (TENS) 市場:各應用領域
    • 治療阻力性憂鬱症
    • 其他
  • 迷走神經刺激設備 (VNS) 市場:各應用領域
    • 癲癇
    • 其他
  • 薦骨神經刺激器 (SNS) 市場:各應用領域
    • 尿失禁
    • 便失禁
  • 視網膜移植市場:各應用領域
    • 色素性視網膜炎
  • 其他電刺激設備市場:各應用領域
    • 胃輕癱
    • 肥胖
    • 憂鬱症
    • 偏頭痛
    • 脊髓損傷

第9章 全球電力藥學市場:各終端用戶

  • 簡介
  • 醫院
  • 研究機關
  • 個人用戶

第10章 全球電力藥學市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

第11章 競爭情形

  • 概要
  • 競爭情形、趨勢
  • 全球電力藥學市場:成長策略的確證評估

第12章 企業簡介 (簡介、產品&服務、策略&分析師的考察、近幾年的發展趨勢、MNM的見解)

  • 簡介
  • MEDTRONIC PLC
  • ST. JUDE MEDICAL, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • COCHLEAR LIMITED
  • SONOVA HOLDING AG
  • LIVANOVA PLC
  • BIOTRONIK
  • NEVRO CORP.
  • SECOND SIGHT MEDICAL PRODUCTS, INC.
  • ELECTROCORE LLC

第13章 附錄

目錄
Product Code: MD 4358

The global electroceuticals/bioelectric medicine market is expected to reach USD 25.20 billion by 2021 from USD 17.20 billion in 2016, growing at a CAGR of 7.9% from 2016 to 2021.

Electroceuticals are medical devices that use electrical impulses to modulate the body's neural circuits as an alternative to drug-based interventions. These electroceutical devices read and modify electrical signals passing along the nerves of the body, including irregular or altered impulses that can occur in association with a broad range of diseases.

The implantable cardioverter defibrillators segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by product, in 2016. Increasing sudden cardiac arrest (SCA) leading to cardiovascular death, technological advancements in ICDs, and increasing arrhythmia is contributing to the large share of this segment. The implantable electroceutical devices segment is expected to account for the largest share of the electroceuticals/bioelectric medicine market, by type of device, in 2016. The rising research in this industry and collaborations and partnerships to development electroceutical devices, these devices providing continuous treatment within the body, and providing an environment for the easy treatment of patients is driving growth in this market segment. The hospitals segment is estimated to account for the largest share of the electroceuticals/bioelectric medicine market, by end user, in 2016. This can be attributed to increasing burden of diseases such as cardiac arrhythmias, Parkinson's, Alzheimer's, retinitis pigmentosa, epilepsy, and depression; and increasing awareness about electroceuticals.

North America is expected to account for the largest share of the global electroceuticals/bioelectric medicine market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, expected approvals for retinal implants, increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada, among others. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rising adoption of neurostimulation, increasing cases of diabetes, increasing prevalence of hearing loss, increasing geriatric population, conferences on electroceutical devices, increasing prevalence of Parkinson's Disease, and regulatory approvals of cochlear implants in the Asia-Pacific region.

The electroceuticals/bioelectric medicine market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, approvals, new product launches, agreements/collaborations/joint ventures/partnerships, marketing and promotion activities, acquisitions and mergers, expansions, market developments, new program launches, and product enhancements) to increase their market shares and establish a stronger foothold in the global market.

Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.) are the key players in the global electroceuticals/bioelectric medicine market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the medical animation market. The report analyzes the market based on product, type of device, application, and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the electroceuticals/bioelectric medicine market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various electroceuticals/bioelectric medicines across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the electroceuticals/bioelectric medicine market
  • Competitive Assessment: In-depth assessment of strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electroceuticals/bioelectric medicine market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
    • 2.2.3. KEY INDUSTRY INSIGHTS
  • 2.3. KEY DATA FROM PRIMARY SOURCES
  • 2.4. KEY INSIGHTS FROM PRIMARY SOURCES
  • 2.5. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.6. RESEARCH DESIGN
  • 2.7. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.8. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL ELECTROCEUTICALS MARKET
  • 4.2. GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT
  • 4.3. GLOBAL ELECTROCEUTICALS MARKET, BY REGION AND DEEP BRAIN STIMULATION APPLICATIONS
  • 4.4. GLOBAL ELECTROCEUTICALS MARKET, BY REGION
  • 4.5. GLOBAL ELECTROCEUTICALS MARKET, BY END USER (2016 VS. 2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising geriatric population
      • 5.2.1.2. Regulatory approval for new and advanced electroceuticals
      • 5.2.1.3. Growing investments and funds for the development of novel therapies and electroceuticals
      • 5.2.1.4. Rising prevalence of neurological disorders
      • 5.2.1.5. Growing prevalence of hearing loss
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of skilled professionals
      • 5.2.2.2. High cost of cochlear implants
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth potential offered by emerging countries
      • 5.2.3.2. Strong product pipeline
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Unfavorable reimbursement scenario

6. GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  • 6.3. CARDIAC PACEMAKERS
  • 6.4. SPINAL CORD STIMULATORS
  • 6.5. COCHLEAR IMPLANTS
  • 6.6. DEEP BRAIN STIMULATORS
  • 6.7. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
  • 6.8. VAGUS NERVE STIMULATORS
  • 6.9. SACRAL NERVE STIMULATORS
  • 6.10. RETINAL IMPLANTS
  • 6.11. OTHER ELECTRICAL STIMULATORS

7. GLOBAL ELECTROCEUTICALS MARKET, BY TYPE OF DEVICE

  • 7.1. INTRODUCTION
  • 7.2. IMPLANTABLE ELECTROCEUTICAL DEVICES
  • 7.3. NON-INVASIVE ELECTROCEUTICAL DEVICES

8. GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CARDIAC PACEMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY APPLICATION
    • 8.2.1. ARRHYTHMIA
  • 8.3. SPINAL CORD STIMULATORS (SCS) MARKET, BY APPLICATION
    • 8.3.1. CHRONIC PAIN
    • 8.3.2. FAILED BACK SYNDROME (FBSS)
    • 8.3.3. ISCHEMIA
  • 8.4. COCHLEAR IMPLANTS MARKET, BY APPLICATION
    • 8.4.1. SENSORINEURAL HEARING LOSS
  • 8.5. DEEP BRAIN STIMULATORS (DBS) MARKET, BY APPLICATION
    • 8.5.1. PARKINSON'S DISEASE
    • 8.5.2. TREMOR
    • 8.5.3. DEPRESSION
    • 8.5.4. OTHER DEEP BRAIN STIMULATION APPLICATIONS
  • 8.6. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS (TENS) MARKET, BY APPLICATION
    • 8.6.1. TREATMENT-RESISTANT DEPRESSION
    • 8.6.2. OTHER TRANSCUTANEOUS ELECTRICAL STIMULATION APPLICATIONS
  • 8.7. VAGUS NERVE STIMULATORS MARKET (VNS), BY APPLICATION
    • 8.7.1. EPILEPSY
    • 8.7.2. OTHER VAGUS NERVE STIMULATION APPLICATIONS
  • 8.8. SACRAL NERVE STIMULATORS (SNS) MARKET, BY APPLICATION
    • 8.8.1. URINARY INCONTINENCE
    • 8.8.2. FECAL INCONTINENCE
  • 8.9. RETINAL IMPLANTS MARKET, BY APPLICATION
    • 8.9.1. RETINITIS PIGMENTOSA
  • 8.10. OTHER ELECTRICAL STIMULATORS MARKET, BY APPLICATION
    • 8.10.1. GASTROPARESIS
    • 8.10.2. OBESITY
    • 8.10.3. DEPRESSION
    • 8.10.4. MIGRAINE
    • 8.10.5. SPINAL CORD INJURY

9. GLOBAL ELECTROCEUTICALS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. RESEARCH INSTITUTES
  • 9.4. INDIVIDUAL USERS

10. GLOBAL ELECTROCEUTICALS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Rising prevalence of arrhythmia in the U.S.
      • 10.2.1.2. Rising prevalence of chronic diseases in the U.S.
      • 10.2.1.3. High prevalence of hearing loss in the U.S.
      • 10.2.1.4. Rising incidence of RP driving the demand for retinal implants
      • 10.2.1.5. Conferences & annual meetings
      • 10.2.1.6. Increasing regulatory approvals in the U.S.
    • 10.2.2. CANADA
      • 10.2.2.1. Growing burden of cancer and diabetes in Canada
      • 10.2.2.2. Increase in hearing loss, owing to rising aging population
  • 10.3. EUROPE
    • 10.3.1. RAPIDLY AGING POPULATION IN EUROPE
    • 10.3.2. CONFERENCES & ANNUAL MEETINGS
    • 10.3.3. GOVERNMENT SUPPORT FOR HEARING IMPLANTS
    • 10.3.4. RISING PREVALENCE OF NEUROLOGICAL DISEASES IN GERMANY AND FRANCE
    • 10.3.5. RISING PREVALENCE OF DIABETES IN THE U.K. AND REST OF EUROPE
    • 10.3.6. INCREASING REGULATORY APPROVALS IN EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. RISING AGING POPULATION DRIVING INCREASE IN DISEASE INCIDENCE IN JAPAN
    • 10.4.2. INCREASING PREVALENCE OF DIABETES AND RAPIDLY AGING POPULATION IN CHINA
    • 10.4.3. INCREASING PREVALENCE OF HEARING LOSS IN ASIA-PACIFIC REGION
    • 10.4.4. INCREASING GERIATRIC POPULATION & HIGH DIABETES PREVALENCE IN INDIA
    • 10.4.5. CONFERENCES ON ELECTROCEUTICAL DEVICES IN APAC
    • 10.4.6. INCREASING PREVALENCE OF PARKINSON'S DISEASE IN SINGAPORE
  • 10.5. REST OF WORLD
    • 10.5.1. RISE IN AGING POPULATION & PREVALENCE OF DIABETES IN THE MIDDLE EAST AND AFRICA
    • 10.5.2. CONFERENCES ON ELECTROCEUTICAL DEVICES IN LATIN AMERICA AND AFRICA
    • 10.5.3. GROWING CASES OF CANCER IN LATIN AMERICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. COMPETITIVE SITUATION AND TRENDS
    • 11.2.1. INTRODUCTION
    • 11.2.2. PRODUCT LAUNCHES
    • 11.2.3. APPROVALS
    • 11.2.4. NEW PRODUCT LAUNCHES
    • 11.2.5. AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS
    • 11.2.6. MARKETING AND PROMOTION ACTIVITIES
    • 11.2.7. ACQUISITIONS AND MERGERS
    • 11.2.8. EXPANSIONS
    • 11.2.9. OTHER STRATEGIES
  • 11.3. GLOBAL ELECTROCEUTICALS MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES
    • 11.3.1. ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES
    • 11.3.2. ORGANIC GROWTH STRATEGIES
    • 11.3.3. INORGANIC GROWTH STRATEGIES

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. MEDTRONIC PLC
  • 12.3. ST. JUDE MEDICAL, INC.
  • 12.4. BOSTON SCIENTIFIC CORPORATION
  • 12.5. COCHLEAR LIMITED
  • 12.6. SONOVA HOLDING AG
  • 12.7. LIVANOVA PLC
  • 12.8. BIOTRONIK
  • 12.9. NEVRO CORP.
  • 12.10. SECOND SIGHT MEDICAL PRODUCTS, INC.
  • 12.11. ELECTROCORE LLC

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. COMPANY DEVELOPMENTS (2013-2016)
    • 13.2.1. MEDTRONIC PLC
    • 13.2.2. ST. JUDE MEDICAL, INC.
    • 13.2.3. BOSTON SCIENTIFIC CORPORATION
    • 13.2.4. COCHLEAR LIMITED
    • 13.2.5. LIVANOVA PLC
    • 13.2.6. BIOTRONIK
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PREVALENCE OF HEARING LOSS, BY REGION, 2012 (MILLION)
  • TABLE 2: GROWING INVESTMENTS AND FUNDS FOR THE DEVELOPMENT OF NOVEL THERAPIES AND ELECTROCEUTICALS DRIVING MARKET GROWTH
  • TABLE 3: LACK OF SKILLED PROFESSIONALS RESTRAINING MARKET GROWTH
  • TABLE 4: EMERGING COUNTRIES TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
  • TABLE 5: UNFAVORABLE REIMBURSEMENT SCENARIO IS A MAJOR CHALLENGE IN THE MARKET
  • TABLE 6: GLOBAL ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL CARDIAC PACEMAKERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: CARDIAC PACEMAKERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: NORTH AMERICA: SPINAL CORD STIMULATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL COCHLEAR IMPLANT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: NORTH AMERICA: COCHLEAR IMPLANT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL DEEP BRAIN STIMULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL VAGUS NERVE STIMULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL SACRAL NERVE STIMULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL RETINAL IMPLANTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)*
  • TABLE 24: NORTH AMERICA: RETINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL OTHER ELECTRICAL STIMULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: OTHER ELECTRICAL STIMULATORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL NON-INVASIVE ELECTROCEUTICAL DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: NON-INVASIVE ELECTROCEUTICAL DEVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL SPINAL CORD STIMULATORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR CHRONIC PAIN, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR CHRONIC PAIN, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR ISCHEMIA, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: SPINAL CORD STIMULATORS APPLICATION MARKET SIZE FOR ISCHEMIA, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 40: GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR PARKINSON'S DISEASE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR PARKINSON'S DISEASE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR TREMORS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR TREMORS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR OTHER DEEP BRAIN STIMULATION APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: DEEP BRAIN STIMULATORS APPLICATION MARKET SIZE FOR OTHER DEEP BRAIN STIMULATION APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER TRANSCUTANEOUS ELECTRICAL STIMULATION APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER TRANSCUTANEOUS ELECTRICAL STIMULATION APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: GLOBAL VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 54: GLOBAL VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR EPILEPSY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR EPILEPSY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: GLOBAL VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER VAGUS NERVE STIMULATION APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: VAGUS NERVE STIMULATORS APPLICATION MARKET SIZE FOR OTHER VAGUS NERVE STIMULATION APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: GLOBAL SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: GLOBAL SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR URINARY INCONTINENCE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR URINARY INCONTINENCE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR FECAL INCONTINENCE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: SACRAL NERVE STIMULATORS APPLICATION MARKET SIZE FOR FECAL INCONTINENCE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: GLOBAL OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 64: GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR GASTROPARESIS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR GASTROPARESIS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR OBESITY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR OBESITY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR DEPRESSION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR MIGRAINE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 71: NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR MIGRAINE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: GLOBAL OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR SPINAL CORD INJURY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: OTHER ELECTRICAL STIMULATORS APPLICATION MARKET SIZE FOR SPINAL CORD INJURY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: GLOBAL ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: GLOBAL ELECTROCEUTICALS MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 76: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 77: GLOBAL ELECTROCEUTICALS MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 79: GLOBAL ELECTROCEUTICALS MARKET SIZE FOR INDIVIDUAL USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 80: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE FOR INDIVIDUAL USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 81: GLOBAL ELECTROCEUTICALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 82: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 83: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 85: NORTH AMERICA: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 86: NORTH AMERICA: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 87: NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 88: NORTH AMERICA: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 89: NORTH AMERICA: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 90: NORTH AMERICA: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 91: NORTH AMERICA: ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 92: U.S.: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 93: U.S.: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 94: U.S.: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 95: U.S.: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 96: U.S.: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97: U.S.: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 98: U.S.: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 99: U.S.: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 100: U.S.: ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 101: CANADA: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 102: CANADA: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 103: CANADA: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 104: CANADA: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 105: CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: CANADA: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 107: CANADA: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 108: CANADA: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 109: CANADA: ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 110: EUROPE: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 111: EUROPE: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 112: EUROPE: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 113: EUROPE: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 114: EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 115: EUROPE: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 116: EUROPE: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 117: EUROPE: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 118: EUROPE: ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 119: ASIA-PACIFIC: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 120: ASIA-PACIFIC: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 121: ASIA-PACIFIC: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 122: ASIA-PACIFIC: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 123: ASIA-PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 124: ASIA-PACIFIC: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 125: ASIA-PACIFIC: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 126: ASIA-PACIFIC: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 127: ASIA-PACIFIC: ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 128: ROW: ELECTROCEUTICALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 129: ROW: ELECTROCEUTICALS MARKET SIZE, BY TYPE OF DEVICE, 2014-2021 (USD MILLION)
  • TABLE 130: ROW: SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 131: ROW: DEEP BRAIN STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 132: ROW: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 133: ROW: VAGUS NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 134: ROW: SACRAL NERVE STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 135: ROW: OTHER ELECTRICAL STIMULATION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 136: ROW: ELECTROCEUTICALS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 137: PRODUCT LAUNCHES, 2013-2016
  • TABLE 138: APPROVALS, 2013-2016
  • TABLE 139: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 140: AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS, 2013-2016
  • TABLE 141: MARKETING AND PROMOTION ACTIVITIES, 2013-2016
  • TABLE 142: ACQUISITIONS AND MERGERS, 2013-2016
  • TABLE 143: EXPANSIONS, 2013-2016
  • TABLE 144: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL ELECTROCEUTICALS/BIOELECTRONIC MEDICINE MARKET SEGMENTATION
  • FIGURE 2: GLOBAL ELECTROCEUTICALS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 4: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL MARKET
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR CARDIAC PACEMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR COCHLEAR IMPLANTS MARKET
  • FIGURE 8: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR RETINAL IMPLANTS MARKET
  • FIGURE 9: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR NEUROMODULATION DEVICES MARKET
  • FIGURE 10: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR THE GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
  • FIGURE 11: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 12: RESEARCH DESIGN
  • FIGURE 13: DATA TRIANGULATION METHODOLOGY
  • FIGURE 14: NON-INVASIVE ELECTROCEUTICAL DEVICES MARKET TO WITNESS HIGH GROWTH RATE FROM 2016 TO 2021
  • FIGURE 15: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SEGMENT TO COMMAND THE LARGEST SHARE OF THE ELECTROCEUTICALS MARKET, BY PRODUCT, IN 2016
  • FIGURE 16: GLOBAL ELECTROCEUTICALS MARKET, BY END USER, 2016-2021
  • FIGURE 17: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ELECTROCEUTICALS MARKET, 2016
  • FIGURE 18: SPINAL CORD STIMULATORS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 19: REGULATORY APPROVAL FOR NEW AND ADVANCED ELECTROCEUTICALS TO DRIVE MARKET GROWTH
  • FIGURE 20: RETINAL IMPLANTS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL ELECTROCEUTICALS MARKET IN 2016
  • FIGURE 22: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: HOSPITALS SEGMENT TO COMMAND THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 24: GLOBAL ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 25: GLOBAL ELECTROCEUTICALS MARKET, BY PRODUCT
  • FIGURE 26: RETINAL IMPLANTS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 27: GLOBAL ELECTROCEUTICALS MARKET SEGMENTATION, BY TYPE OF DEVICE
  • FIGURE 28: NON-INVASIVE ELECTROCEUTICAL DEVICES SEGMENT TO WITNESS HIGHEST CAGR OF 23.3% DURING THE FORECAST PERIOD
  • FIGURE 29: GLOBAL ELECTROCEUTICALS MARKET, BY APPLICATION
  • FIGURE 30: GLOBAL ELECTROCEUTICALS MARKET SEGMENTATION, BY END USER
  • FIGURE 31: INDIVIDUAL USERS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL ELECTROCEUTICALS MARKET IN 2016
  • FIGURE 33: NORTH AMERICAN ELECTROCEUTICALS MARKET SNAPSHOT
  • FIGURE 34: EUROPEAN ELECTROCEUTICALS MARKET SNAPSHOT
  • FIGURE 35: ASIA-PACIFIC ELECTROCEUTICALS MARKET SNAPSHOT
  • FIGURE 36: ROW ELECTROCEUTICALS MARKET SNAPSHOT
  • FIGURE 37: TOP 5 STRATEGIES ADOPTED BY PLAYERS OVER THE LAST THREE YEARS (2013-2016)
  • FIGURE 38: BATTLE FOR MARKET SHARE: MARKET EXPANSION WAS THE KEY STRATEGY (2013 -2016)
  • FIGURE 39: ORGANIC & INORGANIC GROWTH STRATEGIES: INDUSTRY TREND VS. KEY PLAYERS
  • FIGURE 40: ORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013-2016)
  • FIGURE 41: INORGANIC GROWTH STRATEGIES, BY KEY PLAYER (2013-2016)
  • FIGURE 42: PRODUCT MIX OF KEY PLAYERS IN THE MARKET
  • FIGURE 43: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 44: ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 45: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 46: COCHLEAR LIMITED: COMPANY SNAPSHOT
  • FIGURE 47: SONOVA HOLDING AG: COMPANY SNAPSHOT
  • FIGURE 48: LIVANOVA PLC: COMPANY SNAPSHOT
  • FIGURE 49: NEVRO CORP.: COMPANY SNAPSHOT
  • FIGURE 50: SECOND SIGHT MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT
Back to Top